Evidence map›Paper›PMID 29430639›Full record

Observational studyJournal of the American Geriatrics Society2018

Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016.

Jonathan Brett, Donovan T Maust, Zach Bouck, Rosalinda V Ignacio, Graham Mecredy, Eve A Kerr, Sacha Bhatia, Adam G Elshaug, Sallie A Pearson

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the American Geriatrics Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Addressing Problems With Alcohol and Other Substances Among Older Adults During the COVID-19 Pandemic.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonathan BrettMedicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0003-3065-7495
Donovan T MaustCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Zach BouckInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, Ontario, Canada.
Rosalinda V IgnacioCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Graham MecredyInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Eve A KerrCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Sacha BhatiaInstitute for Health Systems Solutions and Virtual Care, Women's College Hospital, Toronto, Ontario, Canada.
Adam G ElshaugMenzies Centre for Health Policy, School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Sallie A PearsonMedicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

Funding

Preventable Hospitalization in Dementia: The Impact of Neuropsychiatric SymptomsK08AG048321 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MAUST, DONOVAN T · 2014 to 2017
$700k
NIA NIH HHS K08 AG048321
6 · The paper itself

Abstract

objectivesTo detail annual trends in benzodiazepine incidence and prevalence in older adults between 2010 and 2016 in three countries.

designObservational multicountry cohort study with harmonized study protocol.

settingThe United States (veteran population); Ontario, Canada; and Australia.

participantsAll people aged 65 and older (8,270,000 people). MEASUREMENTS: Annual incidence and prevalence of benzodiazepine use stratified according to age group (65-74, 75-84, ≥85) and sex. We performed multiple regression analyses to assess whether rates of incident and prevalent use changed significantly over time.

resultsOver the study period, we observed a significant decrease in incident benzodiazepine use in the United States (2.6% to 1.7%) and Ontario (6.0% to 4.4%) but not Australia (7.0% to 6.7%). We found significant declines in prevalent use in all countries (United States: 9.2% to 7.3%; Ontario: 18.2% to 13.4%; Australia: 20.2% to 16.8%). Although incidence and prevalence increased with age in Ontario and Australia, they decreased with age in the United States. Incidence and prevalence were higher in women in all countries.

conclusionConsistent with other international studies, there have been small but significant reductions in the incidence and prevalence of benzodiazepine use in older adults in all three countries, with the exception of incidence in Australia, although use remains inappropriately high-particularly in those aged 85 and older-which warrants further attention from clinicians and policy-makers.

Indexed as

Prescription Drug OveruseAgedAged, 80 and overAustraliaBenzodiazepinesDrug Utilization ReviewFemaleHumansIncidenceMaleOntarioPractice Patterns, Physicians'Prescription DrugsPrevalenceUnited StatesBenzodiazepinesPrescription DrugsAustraliabenzodiazepinesChoosing Wiselyolder adultsOntarioUnited States

Identifiers

PMID29430639
PMCPMC6087688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.